Genetic Insights: FVIII A3 Variants and Inhibitor Risk
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of ISTH, shared on X:
”Deleterious variants cluster in the A3 domain of factor VIII in severe patients with haemophilia A and inhibitors – the role of F8 genotype and specific FVIII domains in inhibitor development in an admixed population of PwHA.”
Read the full article here.
Article: Deleterious variants cluster in the A3 domain of factor VIII in severe patients with haemophilia A and inhibitors
Authors: Luciana Werneck Zuccherato, Renan Pedra Souza, Ricardo Mesquita Camelo, Márcio Antônio Portugal Santana, Maíse Moreira Dias, Letícia Lemos Jardim, Andrea Gonçalves de Oliveira, Claudia Santos Lorenzato, Monica Hermida Cerqueira, Vivian Karla Brognoli Franco, Rosangela de Albuquerque Ribeiro, Leina Yukari Etto, Maria do Rosario Ferraz Roberti, Fábia Michelle Rodrigues de Araújo Callado, Maria Aline Ferreira de Cerqueira, Ieda Solange de Souza Pinto, Andrea Aparecida Garcia, Tania Hissa Anegawa, Daniele Campos Fontes Neves, Daniel Gonçalves Chaves, Suely Meireles Rezende, [email protected] on behalf of the HEMFIL and the Brazilian Immune Tolerance (BrazIT) Study
Stay updated on all science in the field of hematology with Hemostasis Today.
-
Aug 18, 2025, 23:48Pulmonary Embolism Management: Experts Share Valuable Insights on Endovascular Today
-
Aug 18, 2025, 13:21Gehan Lotfy Khalifa and Colleagues Share a Egyptian Pediatric Guidelines for Childhood VTE
-
Aug 18, 2025, 09:45Mark Lewis: aPTT Pathway—What Activates What
-
Aug 18, 2025, 08:48William Aird: Physical Exam in Hit
-
Aug 17, 2025, 23:32Platelets Carry Tumor DNA! Powerful Potential for Liquid Biopsies and Precision Cancer Detection
-
Aug 18, 2025, 11:04Albert Farrugia: The Past, Present and Future of Blood Plasma Fractionation
-
Aug 18, 2025, 09:57Eugene Yang: When Should Prevention of Atherosclerosis Begin?
-
Aug 18, 2025, 09:34SIREN Study: Important Insights Hypertension and Low Vegetable Consumption Double Stroke Odds
-
Aug 18, 2025, 09:03Genetic Insights: FVIII A3 Variants and Inhibitor Risk
-
Aug 17, 2025, 11:34DAPT After PCI: Sex-Specific Strategies Unveiled
-
Aug 16, 2025, 14:42Mark Crowther Honors Davide Matino for Leading Promising Hemophilia Trial at McMaster University
-
Aug 14, 2025, 10:28Impressive 95% Clot Removal in a VTE Case: Symphony16F and Symphony24F Catheters
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Aug 17, 2025, 07:31Melissa Korn's story: Recognizing Pulmonary Embolism Symptoms Can Save Lives, NBCA
-
Aug 16, 2025, 14:18Christelle Orlando Highlights Breakthroughs in Thrombophilia Testing and AT Assays at ISTH 2025
-
Aug 15, 2025, 23:33Kacper Odziomek Excels in 2 Pharmacology Courses from Harvard Medical School
-
Aug 15, 2025, 03:44Call for Global Action on Bleeding Disorders from Baumann, Christoforou and Klamroth
-
Aug 14, 2025, 02:08Jordan Harry's Conversation on Cancer and Clot Risk with Thrombosis Canada